Top Ranked Dividend Stock VIVO Enters Oversold Territory

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Meridian Bioscience Inc. (VIVO) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.

But making Meridian Bioscience Inc. an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of VIVO entered into oversold territory, changing hands as low as $19.15 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

START SLIDESHOW:
Click here to find out what 9 other oversold dividend stocks you need to know about »

In the case of Meridian Bioscience Inc., the RSI reading has hit 28.2 — by comparison, the universe of dividend stocks covered by Dividend Channel currently has an average RSI of 54.2. A falling stock price — all else being equal — creates a better opportunity for dividend investors to capture a higher yield. Indeed, VIVO's recent annualized dividend of 0.76/share (currently paid in quarterly installments) works out to an annual yield of 3.72% based upon the recent $20.42 share price.

A bullish investor could look at VIVO's 28.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. Among the fundamental datapoints dividend investors should investigate to decide if they are bullish on VIVO is its dividend history. In general, dividends are not always predictable; but, looking at the history chart below can help in judging whether the most recent dividend is likely to continue.

VIVO+Dividend+History+Chart

VIVO makes up 1.52% of the S&P SmallCap Health Care Portfolio ETF ( PSCH)

null

More from Stocks

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

Trump, Trade Wars, General Electric, 'Jurassic World' - 5 Things You Must Know

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

How Small-Cap Stocks Can Protect Your Portfolio From a Trade War

How Small-Cap Stocks Can Protect Your Portfolio From a Trade War

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War

Stocks Weaken Around The World as Trump Opens New Fronts in Global Trade War

Trump Puts Tech in Trade War Crosshairs With Planned Curb on China Investment

Trump Puts Tech in Trade War Crosshairs With Planned Curb on China Investment